Science Explorer Back to mapMap
Discussion
Researcher · Norton Healthcare · United States

Don Ambrose Stevens

Don Ambrose Stevens publishes mostly in Oncology, Pathology and Forensic Medicine and Genetics, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

OpenAlex
World rank
#796,567
of 7,710,434 ranked researchers
Rank in United States
#265,934
of 1,627,098
Works
206
Citations
7.2k
Citations per work
34.9
h-index
28
i10-index 71Top 13% in Oncology
Don Ambrose Stevens

What does Don Ambrose Stevens research?

Don Ambrose Stevens's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (7%).

Health Sciences: 125 works · 60.7% of their workMedicine: 125 works · 60.7% of their workOncology: 36 works · 17.7% of their workPathology and Forensic Medicine: 33 works · 15.8% of their workGenetics: 31 works · 15.1% of their workHematology: 25 works · 12.1% of their workEverything else: 52 works · 25.0% of their workLife Sciences: 29 works · 14.3% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 7.4% of their workMolecular Biology: 15 works · 7.4% of their workImmunology and Microbiology: 14 works · 6.9% of their workImmunology: 14 works · 6.9% of their workTHEIR WORKDon AmbroseStevens206works
Life Sciences14%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12560.7%
  2. Everything else5225.0%
    1. Biochemistry, Genetics and Molecular Biology157.4%
    2. Immunology and Microbiology146.9%
  1. 1Oncology18% of their works
  2. 2Pathology and Forensic Medicine16% of their works
  3. 3Genetics15% of their works
  4. 4Hematology12% of their works
  5. 5Molecular Biology7% of their works
  6. 6Immunology7% of their works

Research topics

Which keywords describe Don Ambrose Stevens's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Prognostic Factors, Classification, Molecular Profiling, Chronic Lymphocytic Leukemia, Genomic Aberrations and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Rituximab1672 topics
  2. Lymphoma1462 topics
  3. Prognostic Factors1143 topics
  4. Classification861 topic
  5. Molecular Profiling861 topic
  6. Chronic Lymphocytic Leukemia811 topic
  7. Genomic Aberrations811 topic
  8. CAR T Cells601 topic
  9. Chimeric Antigen Receptor601 topic
  10. Monoclonal Antibodies482 topics
  11. Diagnosis Criteria391 topic
  12. International Myeloma Working Group391 topic
  13. Fc Receptors321 topic
  14. Therapeutic Antibodies321 topic
  15. AML171 topic
  16. Acute Myeloid Leukemia171 topic
  17. Biosimilars161 topic
  18. Cutaneous Lymphomas161 topic
  19. Immunogenicity161 topic
  20. Mycosis Fungoides161 topic

Where does Don Ambrose Stevens work?

Don Ambrose Stevens's main affiliation in the publication record is Norton Healthcare, United States.

How many publications and citations does Don Ambrose Stevens have?

OpenAlex counts 206 works and 7,190 citations for Don Ambrose Stevens, an h-index of 28, ranking #796,567 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Don Ambrose Stevens. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.